This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Moving from Batch to Continuous
The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?
